Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 1.66
(3.75%)
HKD 1.66
(3.75%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 183 Thousand CNY | -98.26% |
| 2022 | 10.48 Million CNY | -30.7% |
| 2021 | 15.13 Million CNY | 18818.75% |
| 2020 | 80 Thousand CNY | -64.29% |
| 2019 | 224 Thousand CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - CNY | 0.0% |
| 2024 Q2 | - CNY | 0.0% |
| 2023 Q2 | 7.5 Million CNY | 0.0% |
| 2023 FY | 183 Thousand CNY | -98.26% |
| 2023 Q1 | 7.5 Million CNY | -28.46% |
| 2023 Q3 | 183 Thousand CNY | -97.56% |
| 2023 Q4 | 183 Thousand CNY | 0.0% |
| 2022 Q2 | - HKD | 0.0% |
| 2022 FY | 10.48 Million CNY | -30.7% |
| 2022 Q4 | 10.48 Million CNY | 0.0% |
| 2022 Q3 | 10.48 Million CNY | 0.0% |
| 2021 Q4 | - HKD | 0.0% |
| 2021 FY | 15.13 Million CNY | 18818.75% |
| 2020 FY | 80 Thousand CNY | -64.29% |
| 2019 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 30.61 Million HKD | 99.402% |
| CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 99.996% |